Tafenoquine is currently approved for malaria prophylaxis but has not yet been proven safe or effective for babesiosis. The study is supported by the U.S. Army Medical & Materiel Development Activity.

The main focus in this article is about cost–effectiveness of malaria patients in endemic areas treated therapeutically and using prophylaxis (IPT) when indicated. The cost–effectiveness with ...

Tafenoquine was approved for malaria prophylaxis in 2018 in the United States as ARAKODA® and in Australia as KODATEF®. Both were commercially launched in 2019 and are currently ...

With malaria being one of the most significant causes of morbidity and mortality worldwide, prompt and effective treatment is essential to reduce the malaria burden. As there are several treatment ...

About ARAKODA® (tafenoquine) Tafenoquine is approved for malaria prophylaxis in the United States under the product name ARAKODA®. The safety of the approved regimen of tafenoquine for malaria ...

Now, the company has released its first truly winterized hiking boots, and I’ve been wearing them for two weeks during the deepest part of winter. They took a little breaking in, but they live ...

“As babesiosis continues to emerge in new regions of the U.S., the need to address its impact safely and effectively is also growing,” said 60 Degrees Pharmaceuticals, Inc. Chief Executive ...

Elvis Presley earns his second No. 1 on Billboard's Top Rock Albums chart as The Classic Christmas ... [+] Album finally hits the top spot years after its release. BURBANK, CA - JUNE 27 ...

The Official UK Singles Chart reflects the UK’s biggest songs of the week, based on audio and video streams, downloads, CDs and vinyl, compiled by the Official Charts Company. The UK Top 40 is ...

The Official UK Singles Chart reflects the UK’s biggest songs of the week, based on audio and video streams, downloads, CDs and vinyl, compiled by the Official Charts Company. The UK Top 40 is ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

A new UEFI Secure Boot bypass vulnerability tracked as CVE-2024-7344 that affects a Microsoft-signed application could be exploited to deploy bootkits even if Secure Boot protection is active.